Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05874882
Status:
RECRUITING
Last Update Posted:
2023-05-25
First Post:
2023-04-27
Brief Title:
Evaluating the Efficacy of Resveratrol Containing Mouthwash as Adjunct Treatment Periodontitis
Sponsor:
University of Baghdad
Organization:
University of Baghdad
Study Overview
Official Title:
Evaluating the Efficacy of Resveratrol Containing Mouthwash as Adjunct Treatment for Periodontitis
Status:
RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
resveratrol
Brief Summary:
To evaluate the effectiveness of resveratrol mouthwash as adjunct to NSP treatment of periodontitis
Detailed Description:
Measuring and comparing the efficacy of RV mouth wash in comparison with CHX and placebo mouth wash in improving the clinical periodontal parameters
Measuring the salivary cytokines IL-6 before and after 4weeks of the use of RV mouth wash as adjunct to NSP treatment in comparison with other mouthwash by using enzyme-linked immunosorbent assay
Measuring the salivary RANKL before and after 4weeks of the use of RV mouth wash as adjunct to NSP treatment in comparison with other mouthwash by using enzyme-linked immunosorbent assay
Correlate the salivary cytokines IL-6 and salivary RANKL with clinical periodontal parameter and with each other
Evaluate the intervention by using Visual analog scale VAS- score-based questionnaire will be filled out by each participant at the end of the trial
Measuring the salivary cytokines IL-6 before and after 4weeks of the use of RV mouth wash as adjunct to NSP treatment in comparison with other mouthwash by using enzyme-linked immunosorbent assay
Measuring the salivary RANKL before and after 4weeks of the use of RV mouth wash as adjunct to NSP treatment in comparison with other mouthwash by using enzyme-linked immunosorbent assay
Correlate the salivary cytokines IL-6 and salivary RANKL with clinical periodontal parameter and with each other
Evaluate the intervention by using Visual analog scale VAS- score-based questionnaire will be filled out by each participant at the end of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None